Navigation Links
Drugs warning -- check the label
Date:2/2/2011

A new study highlights inconsistencies in black box warnings - medication-related safety warnings on a drug's label - and argues for a more transparent and systematic approach to ensure these warnings are consistent across all drugs within a same category, and any additions to warnings, on the back of a drug withdrawal for example, are done within a reasonable and uniform time period. The work by Orestis Panagiotou and John Ioannidis and colleagues from the University of Ioannina School of Medicine in Greece and Stanford University School of Medicine in the USA is published in Springer's journal Journal of General Internal Medicine.

Black box warnings are the strongest medication-related safety warnings that can be placed in a drug's labelling information, according to the FDA. Their purpose is to highlight major drug-related risks. Because serious drug-related adverse events tend to be down to the pharmacological class of drug rather than to the individual drug, most black box warnings are typically applied to all members of a given class of drugs.

Panagiotou and team looked at how consistent black box warning labelling is across same-class drugs in order to assess whether some drugs fail to carry a warning when black box warnings exist for other drugs in the category, as well as whether there are differences in the time it takes to add a warning to drugs in the same class. They studied the labels of 20 drug classes (176 drugs in total) selected from the USA's 'Top 200 Drugs for 2008 by Sales'. Of these 20 categories, 10 had at least one black box warning while the other 10 had none.

The authors identified differences in 9 of the 20 classes, with 15 black box warnings not present on all the labels of drugs in the same class. For 10 of these 15 different warnings, the information was included elsewhere on the labels as simple warnings or text. For the remaining 5, the black box context was not found anywhere else on the drugs' labels. Significantly, withdrawn drugs tended not to have a black box warning before their withdrawal and the reason for their withdrawal rarely became a black box warning for the other drugs in the same category.

In addition, among the 10 drug classes with at least one warning, there was a considerable time-lag in black box warning acquisition in 8 categories, ranging from 2 months to 14 years in some cases.

The authors argue that labels should mention and justify why a major recognized risk is not an issue for a particular agent in the same class, where other members have demonstrated major toxicity. In their view, unjustified omission of a black box warning may leave patients largely unaware of potential risks.

Orestis Panagiotou and colleagues conclude: " Our findings imply that the process of black box warning acquisition requires transparent and systematic rules, as well as clear justification for the presence of, or lack of evidence for, specific major risks for individual drugs."


'/>"/>

Contact: Renate Bayaz
renate.bayaz@springer.com
49-622-148-78531
Springer
Source:Eurekalert  

Related medicine news :

1. Too Few Get Needed Rheumatoid Arthritis Drugs: Study
2. Smart lasers could make cancer biopsies painless, help speed new drugs to market
3. New Oral Drugs Hailed for Treating MS
4. Not All Heart Failure Drugs Boost Survival Equally
5. Epilepsy Drugs May Raise Fracture Risk in Older Adults
6. Drugs for hair loss and BPH may result in loss of libido, ED in men
7. Evidence lacking for widespread use of costly antipsychotic drugs, says Stanford researcher
8. Studies Decipher How Anti-Smoking Drugs Work
9. Structure of key molecule in immune system provides clues for designing drugs
10. Heartburn Drugs May Raise Pneumonia Risk
11. Trio of drugs may combat triple negative breast cancer
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Drugs warning -- check the label
(Date:12/6/2016)... ... December 06, 2016 , ... Why does the prevalence of obesity continue to ... includes a fresh look into the cause of obesity in his new book “Body ... the knowledge needed to lead a healthy life. Proietto said understanding the regulation of ...
(Date:12/6/2016)... ... ... It can be argued that people these days spend as much time searching ... their human friends and family. As pets have assumed a bigger role in ... pet products has also increased. , For this reason, America’s Pet Health ...
(Date:12/6/2016)... ... December 06, 2016 , ... The Behavioral ... of Distinction, recognizing the organization as a top behavioral service provider in the ... of clinical quality, staff satisfaction and qualifications, and consumer satisfaction. These areas are ...
(Date:12/6/2016)... ... December 06, 2016 , ... Gateway Analytical, ... offering HIAC particle counting and sizing services for USP 788 and 789 particulate ... new service as a response to the needs of pharmaceutical and medical device ...
(Date:12/6/2016)... , ... December 06, 2016 ... ... on Friday, November 25th, when SevenPoint2 released the much-anticipated HydroFX for Water®. ... eye-catching label design. Featuring one of the world’s most powerful antioxidants, molecular ...
Breaking Medicine News(10 mins):
(Date:12/6/2016)... 2016  Viking Therapeutics, Inc. ("Viking") (NASDAQ: ... on the development of novel therapies for metabolic ... Food and Drug Administration (FDA) has granted orphan ... X-linked adrenoleukodystrophy (X-ALD).  VK0214 is a novel, orally ... regulates the expression of genes believed to be ...
(Date:12/6/2016)... 2016 Breast Pump Market size is estimated ... by Global Market Insights, Inc. Continue Reading ... ... , , ... women employment rates and rising consumer awareness regarding importance of breast feeding will ...
(Date:12/6/2016)... , Dec. 6, 2016 In this ... reason to be hopeful.  A special kind of sunglasses, ... less anxious life. Photo - ... Robert Buck, the psychotherapist who developed and patented ... approach to overcoming anxiety and worry.  "Anxiety doesn,t ...
Breaking Medicine Technology: